Melphalan 200 mg/m(2) versus melphalan 100 mg/m(2) in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study
published in: Blood
date of publication: 2009-12-01
language: English
main subject: multicenter clinical trial
Cites articles
There is nothing here
Article - wd:Q33387332